GPFT · Grapefruit USA, Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0K | $24.1K | $5.7K | - | $153.5K | $82.5K | $350.8K | - | $1.31M | $880.7K |
| Cost of Revenue | $62.8K | $162.4K | $71.9K | - | $346.1K | $157.2K | $423.4K | - | $1.12M | $134.9K |
| Gross Profit | ($59.8K) | ($138.4K) | ($66.2K) | - | ($192.6K) | ($74.7K) | ($72.6K) | - | $182.5K | ($131.6K) |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $341.7K | $728.0K | $224.0K | - | $352.5K | $274.7K | $401.4K | - | $289.8K | $420.9K |
| Total Operating Expenses | $342.8K | $728.0K | $239.5K | - | $415.1K | $527.6K | $405.0K | - | $357.2K | $420.9K |
| D&A | - | - | $23.7K | - | - | - | $22.6K | - | - | - |
| Operating Income | ($402.6K) | ($866.4K) | ($305.8K) | - | ($607.7K) | ($602.3K) | ($477.6K) | - | ($174.8K) | ($349.6K) |
| Interest Expense | - | - | $295.9K | - | $388.3K | $449.0K | $421.4K | - | $532.4K | $437.1K |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($758.2K) | ($1.35M) | ($484.3K) | - | ($981.8K) | ($1.35M) | ($1.42M) | - | ($7.69M) | $392.2K |
| EPS - Basic | $0.00 | $0.00 | $0.00 | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.6K | $5.0K | $5.2K | $9.1K | $37.3K | $188.2K | $441.0K | $299.9K | $165.8K | $101.0K |
| Accounts Receivable | $23.0K | $22.4K | $278.4K | $278.4K | $285.6K | $228.1K | $245.8K | $39.4K | - | $17.7K |
| Inventory | $337.5K | $339.3K | $383.2K | $389.3K | $410.7K | $540.3K | $490.8K | $502.1K | $410.7K | $252.8K |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $644.5K | $404.7K | $701.0K | $714.2K | $847.9K | $1.09M | $1.25M | $948.9K | $601.6K | $378.9K |
| Total Assets | $2.72M | $2.39M | $2.76M | $2.82M | $3.04M | $3.15M | $3.34M | $3.05M | $2.74M | $2.50M |
| Current Liabilities | $7.91M | $7.28M | $8.10M | $7.70M | $4.79M | $4.46M | $6.91M | $4.38M | $13.62M | $6.45M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $8.84M | $8.20M | $9.03M | $8.63M | $7.25M | $6.71M | $9.08M | $7.73M | $15.84M | $8.44M |
| Stockholders' Equity | ($6.12M) | ($5.80M) | ($6.26M) | ($5.81M) | ($4.21M) | ($3.56M) | ($5.74M) | ($4.68M) | ($13.10M) | ($5.94M) |
| Retained Earnings | ($19.43M) | ($18.68M) | ($17.31M) | ($16.83M) | ($15.07M) | ($14.08M) | ($12.74M) | ($11.32M) | ($17.33M) | ($9.65M) |
Cash Flow
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($257.4K) | - | - | - | ($261.0K) | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | ($30.5K) | - | - | - |
| Financing Cash Flow | - | - | $253.4K | - | - | - | $432.6K | - | - | - |
| CapEx | - | - | - | - | - | - | $30.5K | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | ($291.6K) | - | - | - |
Ratios
| Metric | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | -2018.8% | -575.1% | -1171.9% | - | -125.5% | -90.5% | -20.7% | - | 14.0% | -14.9% |
| Operating margin | -13593.2% | -3600.5% | -5411.5% | - | -396.0% | -730.1% | -136.1% | - | -13.4% | -39.7% |
| EBITDA margin | - | - | -4992.1% | - | - | - | -129.7% | - | - | - |
| Net margin | -25597.8% | -5596.5% | -8570.9% | - | -639.7% | -1632.5% | -403.8% | - | -588.7% | 44.5% |
| Free cash flow margin | - | - | - | - | - | - | -83.1% | - | - | - |
| FCF / Net income | - | - | - | - | - | - | 0.21 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 11534.8% | 3025.4% | 3964.3% | - | 229.7% | 333.1% | 114.4% | - | 22.2% | 47.8% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -27.9% | -56.3% | -17.6% | - | -32.3% | -42.7% | -42.4% | - | -280.4% | 15.7% |
| Return on equity | 12.4% | 23.2% | 7.7% | - | 23.3% | 37.9% | 24.7% | - | 58.7% | -6.6% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.08 | 0.06 | 0.09 | 0.09 | 0.18 | 0.24 | 0.18 | 0.22 | 0.04 | 0.06 |
| Quick ratio | 0.04 | 0.01 | 0.04 | 0.04 | 0.09 | 0.12 | 0.11 | 0.10 | 0.01 | 0.02 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.06 | 0.07 | 0.01 | 0.02 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | -1.0x | - | -1.6x | -1.3x | -1.1x | - | -0.3x | -0.8x |
| Equity multiplier | -0.44 | -0.41 | -0.44 | -0.48 | -0.72 | -0.89 | -0.58 | -0.65 | -0.21 | -0.42 |
| Liabilities / Assets | 3.26 | 3.43 | 3.28 | 3.06 | 2.39 | 2.13 | 2.72 | 2.53 | 5.78 | 3.38 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | 0.01 | 0.00 | - | 0.05 | 0.03 | 0.11 | - | 0.48 | 0.35 |
| Inventory turnover | 0.19 | 0.48 | 0.19 | - | 0.84 | 0.29 | 0.86 | - | 2.74 | 0.53 |
| Days sales outstanding | 2831d | 339d | 17982d | - | 679d | 1009d | 256d | - | - | 7d |
| Days inventory outstanding | 1963d | 762d | 1947d | - | 433d | 1255d | 423d | - | 133d | 684d |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -98.1% | -70.8% | -98.4% | - | -88.3% | -90.6% | -10.9% | - | 927.7% | - |
| Revenue CAGR (3y) | -71.4% | - | - | - | 214.2% | 156.4% | - | - | 541.6% | 464.6% |
| Revenue CAGR (5y) | -9.7% | 37.5% | 3.4% | - | 45.9% | 71.4% | 97.7% | - | 67.2% | 77.8% |
| Gross profit growth (YoY) | 69.0% | -85.3% | 8.8% | - | - | 43.3% | -18.2% | - | 239.4% | - |
| Operating income growth (YoY) | 33.7% | -43.8% | 36.0% | - | -247.7% | -72.3% | -31.2% | - | 76.9% | 49.0% |
| Net income growth (YoY) | 22.8% | 0.0% | 65.8% | - | 87.2% | - | 48.9% | - | -163.7% | -97.1% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | 23.8% | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -45.4% | -63.0% | -9.2% | -24.1% | 67.9% | 40.2% | 12.2% | -5.5% | - | -66.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Product / service
$3.67M totalBulk Sales$3.67M · 99.9%
Distribution Services$5.2K · 0.1%
Peer comparison
Same SIC group: X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Comparing Grapefruit USA against the 4 most active filers in the same SIC group.